Caspase-14 but not caspase-3 is processed during the development of fetal mouse epidermis.

The activation of caspases is a central step in apoptosis and may also be critical for terminal differentiation of epidermal keratinocytes (KC). In particular, caspase-3 has been implicated in the differentiation of embryonic KC as well as in programmed cell death of KC, and caspase-14 has been suggested to function in the formation or homeostasis of the stratum corneum (SC). To test the putative roles of these proteases, we determined their expression level and activation status during development of fetal mouse epidermis. The level of procaspase-3 did not change significantly during epidermal development, and enzyme activation was undetectable at any timepoint investigated. Despite the lack of active caspase-3, the newly formed stratum granulosum and the regressing periderm contained cells positive in the terminal deoxynucleotidyl transferase-mediated fluorescein-dUTP nick end labeling assay, indicating that nuclear DNA was degraded without activation of caspase-3, thereby arguing against a proteolytic function of caspase-3 in embryonic KC differentiation. By contrast, caspase-14 increased in abundance from embryonic day 14.5 (E14.5) onwards and consistently localized to the suprabasal layers of fetal epidermis. The caspase-14 pro-enzyme was processed into its catalytic subunits, a step required for enzyme activity, on day E17.5, coinciding with SC formation. Thus, processing of procaspase-14 is not confined to air-exposed mature skin but also occurs during epidermal development in utero. In summary, this study demonstrates that caspase-14, but not caspase-3 activation coincides temporally and spatially with embryonic KC differentiation, suggesting a role for caspase-14 in terminally differentiated KC.

[1]  L. Eckhart,et al.  Ultrastructural Localization of Caspase-14 in Human Epidermis , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  L. Eckhart,et al.  Stratum corneum‐derived caspase‐14 is catalytically active , 2004, FEBS letters.

[3]  G. Kirfel,et al.  Simultaneous cell death and desquamation of the embryonic diffusion barrier during epidermal development. , 2004, Experimental cell research.

[4]  M. Mildner,et al.  Retinoic Acid Increases the Expression of p53 and Proapoptotic Caspases and Sensitizes Keratinocytes to Apoptosis , 2004, Cancer Research.

[5]  T. Kang,et al.  Caspase-8 Serves Both Apoptotic and Nonapoptotic Roles1 , 2004, The Journal of Immunology.

[6]  P. Vandenabeele,et al.  Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures. , 2004, The American journal of pathology.

[7]  J. Mikolajczyk,et al.  Activation and substrate specificity of caspase-14. , 2004, Biochemistry.

[8]  F. Martinon,et al.  Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.

[9]  E. Wagner,et al.  Loss of Vascular Endothelial Growth Factor A Activity in Murine Epidermal Keratinocytes Delays Wound Healing and Inhibits Tumor Formation , 2004, Cancer Research.

[10]  G. Dotto,et al.  High commitment of embryonic keratinocytes to terminal differentiation through a Notch1-caspase 3 regulatory mechanism. , 2004, Developmental cell.

[11]  G. Cohen,et al.  Intermediate filaments control the intracellular distribution of caspases during apoptosis. , 2004, The American journal of pathology.

[12]  Alexei Degterev,et al.  A decade of caspases , 2003, Oncogene.

[13]  T. Mak,et al.  Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity , 2003, Nature Immunology.

[14]  L. Mortier,et al.  Terminal differentiation of human epidermal keratinocytes involves mitochondria- and caspase-dependent cell death pathway , 2003, Cell Death and Differentiation.

[15]  E. Gratton,et al.  Neonatal development of the stratum corneum pH gradient: localization and mechanisms leading to emergence of optimal barrier function. , 2003, The Journal of investigative dermatology.

[16]  H. Mannherz,et al.  Premature keratinocyte death and expression of marker proteins of apoptosis in human skin after UVB exposure , 2003, Archives of Dermatological Research.

[17]  Denis Bouchard,et al.  Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. , 2003, Genes & development.

[18]  P. Vandenabeele,et al.  Caspase-14 is expressed in the epidermis, the choroid plexus, the retinal pigment epithelium and thymic Hassall's bodies , 2003, Cell Death and Differentiation.

[19]  L. Eckhart,et al.  Caspase-14 expression by epidermal keratinocytes is regulated by retinoids in a differentiation-associated manner. , 2002, The Journal of investigative dermatology.

[20]  M. Kuechle,et al.  Processing of native caspase-14 occurs at an atypical cleavage site in normal epidermal differentiation. , 2002, Biochemical and biophysical research communications.

[21]  M. Kuechle,et al.  Caspase-14, a keratinocyte specific caspase: mRNA splice variants and expression pattern in embryonic and adult mouse , 2001, Cell Death and Differentiation.

[22]  S Lippens,et al.  Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. , 2000, The Journal of investigative dermatology.

[23]  P. Vandenabeele,et al.  Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing , 2000, Cell Death and Differentiation.

[24]  L. Eckhart,et al.  Caspase-14: analysis of gene structure and mRNA expression during keratinocyte differentiation. , 2000, Biochemical and biophysical research communications.

[25]  R. Sékaly,et al.  Early Activation of Caspases during T Lymphocyte Stimulation Results in Selective Substrate Cleavage in Nonapoptotic Cells , 1999, The Journal of experimental medicine.

[26]  M. Raff,et al.  Caspase activation in the terminal differentiation of human epidermal keratinocytes , 1999, Current Biology.

[27]  L. Goldsmith,et al.  Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes , 1999, Experimental dermatology.

[28]  C. Byrne,et al.  Patterned acquisition of skin barrier function during development. , 1998, Development.

[29]  E. Sideras-Haddad,et al.  Formation of the epidermal calcium gradient coincides with key milestones of barrier ontogenesis in the rodent. , 1998, The Journal of investigative dermatology.

[30]  D. Roop,et al.  Loricrin expression is coordinated with other epidermal proteins and the appearance of lipid lamellar granules in development. , 1995, The Journal of investigative dermatology.

[31]  E. Fuchs,et al.  Programming gene expression in developing epidermis. , 1994, Development.

[32]  M. Mildner,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin impairs differentiation of normal human epidermal keratinocytes in a skin equivalent model. , 2005, The Journal of investigative dermatology.

[33]  S. Hsu,et al.  Psoriasis is characterized by altered epidermal expression of caspase 14, a novel regulator of keratinocyte terminal differentiation and barrier formation. , 2005, Journal of dermatological science.